The 2020 WHO classification of tumors of bone: an updated review

JH Choi, JY Ro - Advances in anatomic pathology, 2021 - journals.lww.com
Bone tumors are a rare and heterogeneous group of neoplasms that occur in the bone. The
diversity and considerable morphologic overlap of bone tumors with other mesenchymal …

Histiocytic disorders

KL McClain, C Bigenwald, M Collin… - Nature Reviews …, 2021 - nature.com
The historic term 'histiocytosis' meaning 'tissue cell'is used as a unifying concept for
diseases characterized by pathogenic myeloid cells that share histological features with …

Persistent post–COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium

JB Finlay, DH Brann, R Abi Hachem, DW Jang… - Science translational …, 2022 - science.org
SARS-CoV-2 causes profound changes in the sense of smell, including total smell loss.
Although these alterations are often transient, many patients with COVID-19 exhibit olfactory …

Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification

AM Leader, JA Grout, BB Maier, BY Nabet, MD Park… - Cancer cell, 2021 - cell.com
Immunotherapy is a mainstay of non-small cell lung cancer (NSCLC) management. While
tumor mutational burden (TMB) correlates with response to immunotherapy, little is known …

Genomic profiling for clinical decision making in lymphoid neoplasms

L De Leval, AA Alizadeh, PL Bergsagel… - Blood, The Journal …, 2022 - ashpublications.org
With the introduction of large-scale molecular profiling methods and high-throughput
sequencing technologies, the genomic features of most lymphoid neoplasms have been …

Langerhans cell histiocytosis

C Rodriguez-Galindo, CE Allen - Blood, The Journal of the …, 2020 - ashpublications.org
Langerhans cell histiocytosis (LCH) is caused by clonal expansion of myeloid precursors
that differentiate into CD1a+/CD207+ cells in lesions that leads to a spectrum of organ …

Efficacy of MEK inhibition in patients with histiocytic neoplasms

EL Diamond, BH Durham, GA Ulaner, E Drill, J Buthorn… - Nature, 2019 - nature.com
Histiocytic neoplasms are a heterogeneous group of clonal haematopoietic disorders that
are marked by diverse mutations in the mitogen-activated protein kinase (MAPK) pathway …

Dendritic cell subsets and locations

S Balan, M Saxena, N Bhardwaj - International review of cell and molecular …, 2019 - Elsevier
Dendritic cells (DCs) are a unique class of immune cells that act as a bridge between innate
and adaptive immunity. The discovery of DCs by Cohen and Steinman in 1973 laid the …

Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders

CM Wilk, F Cathomas, O Török, J Le Berichel, MD Park… - Immunity, 2023 - cell.com
Neurodegenerative diseases (ND) are characterized by progressive loss of neuronal
function. Mechanisms of ND pathogenesis are incompletely understood, hampering the …

Histiocytic neoplasms, version 2.2021, NCCN clinical practice guidelines in oncology

RS Go, E Jacobsen, R Baiocchi, I Buhtoiarov… - Journal of the National …, 2021 - jnccn.org
Histiocytic neoplasms are rare hematologic disorders accounting for less than 1% of cancers
of the soft tissue and lymph nodes. Clinical presentation and prognosis of these disorders …